These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22728091)

  • 1. RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.
    Dwyer CA; Baker E; Hu H; Matthews RT
    Neuroscience; 2012 Sep; 220():47-61. PubMed ID: 22728091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.
    Dwyer CA; Katoh T; Tiemeyer M; Matthews RT
    J Biol Chem; 2015 Apr; 290(16):10256-73. PubMed ID: 25737452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and biochemical characterization of O-mannose-linked human natural killer-1 glycan expressed on phosphacan in developing mouse brains.
    Morise J; Kizuka Y; Yabuno K; Tonoyama Y; Hashii N; Kawasaki N; Manya H; Miyagoe-Suzuki Y; Takeda S; Endo T; Maeda N; Takematsu H; Oka S
    Glycobiology; 2014 Mar; 24(3):314-24. PubMed ID: 24352591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression.
    Hu H; Li J; Zhang Z; Yu M
    Neurosci Lett; 2011 Feb; 489(1):10-5. PubMed ID: 21129441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major glycan structure underlying expression of the Lewis X epitope in the developing brain is O-mannose-linked glycans on phosphacan/RPTPβ.
    Yaji S; Manya H; Nakagawa N; Takematsu H; Endo T; Kannagi R; Yoshihara T; Asano M; Oka S
    Glycobiology; 2015 Apr; 25(4):376-85. PubMed ID: 25361541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycomic analyses of mouse models of congenital muscular dystrophy.
    Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
    J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
    Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
    Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosyltransferase POMGNT1 deficiency strengthens N-cadherin-mediated cell-cell adhesion.
    Noor SI; Hoffmann M; Rinis N; Bartels MF; Winterhalter PR; Hoelscher C; Hennig R; Himmelreich N; Thiel C; Ruppert T; Rapp E; Strahl S
    J Biol Chem; 2021; 296():100433. PubMed ID: 33610554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1).
    Liu J; Ball SL; Yang Y; Mei P; Zhang L; Shi H; Kaminski HJ; Lemmon VP; Hu H
    Mech Dev; 2006 Mar; 123(3):228-40. PubMed ID: 16458488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.
    Voglmeir J; Kaloo S; Laurent N; Meloni MM; Bohlmann L; Wilson IB; Flitsch SL
    Biochem J; 2011 Jun; 436(2):447-55. PubMed ID: 21361872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
    Manya H; Endo T
    Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.
    Uribe ML; Haro C; Ventero MP; Campello L; Cruces J; Martín-Nieto J
    Mol Vis; 2016; 22():658-73. PubMed ID: 27375352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-mannosylation in mammalian cells.
    Endo T; Manya H
    Methods Mol Biol; 2006; 347():43-56. PubMed ID: 17072003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
    Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
    Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Finding of O-mannosyl glycan in mammals and congenital muscular dystrophies due to glycosylation defects].
    Endo T
    Yakugaku Zasshi; 2003 Oct; 123(10):825-35. PubMed ID: 14577328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration.
    Tachikawa M; Kanagawa M; Yu CC; Kobayashi K; Toda T
    J Biol Chem; 2012 Mar; 287(11):8398-406. PubMed ID: 22275357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GTDC2 modifies O-mannosylated α-dystroglycan in the endoplasmic reticulum to generate N-acetyl glucosamine epitopes reactive with CTD110.6 antibody.
    Ogawa M; Nakamura N; Nakayama Y; Kurosaka A; Manya H; Kanagawa M; Endo T; Furukawa K; Okajima T
    Biochem Biophys Res Commun; 2013 Oct; 440(1):88-93. PubMed ID: 24041696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and molecular characterization of a patient with muscle-eye-brain disease: a novel mutation in the POMGNT1 gene.
    Raducu M; Cotarelo RP; Simón R; Camacho A; Rubio-Fernández M; Hernández-Laín A; Cruces J
    J Child Neurol; 2014 Feb; 29(2):289-94. PubMed ID: 24282183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents.
    Zhang W; Vajsar J; Cao P; Breningstall G; Diesen C; Dobyns W; Herrmann R; Lehesjoki AE; Steinbrecher A; Talim B; Toda T; Topaloglu H; Voit T; Schachter H
    Clin Biochem; 2003 Jul; 36(5):339-44. PubMed ID: 12849864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.
    Beltrán-Valero de Bernabé D; Currier S; Steinbrecher A; Celli J; van Beusekom E; van der Zwaag B; Kayserili H; Merlini L; Chitayat D; Dobyns WB; Cormand B; Lehesjoki AE; Cruces J; Voit T; Walsh CA; van Bokhoven H; Brunner HG
    Am J Hum Genet; 2002 Nov; 71(5):1033-43. PubMed ID: 12369018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.